MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2020-21)
- Udyam number
- UDYAM-TS-20-0004478
Favnox Pharmaceuticals Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹8.66 Cr
▲ 258% YoY
Net profit · FY 2024
₹8.9 Lakh
Net margin 1%
EBITDA · FY 2024
₹14.81 Lakh
EBITDA margin 1.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Favnox Pharmaceuticals Private Limited
Data last updated:
Favnox Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2020PTC143312. Its GSTIN is 36AAECF2118H1ZX (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sushant Kumar Gantayata and Avanti Malve.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 92 Kanaka Durga Nagar Chengicherla, Hyderabad, Telangana, India – 500092.
As per the financials filed for FY 2024, the company reported a revenue of ₹8.66 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹8.9 Lakh (net margin 1%) and EBITDA of ₹14.81 Lakh (EBITDA margin 1.7%). Revenue has grown at a compounded annual rate (CAGR) of 77% over three years.
Favnox Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0004478). For more details, the company can be reached via its website favnox.in.
Company details
CIN U24239TG2020PTC143312
Registration Number 143312
Incorporation Date 29 August 2020
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-TS-20-0004478
Recognitions & Rankings of Favnox Pharmaceuticals
Contact details
Favnox Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its website is favnox.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No 92 Kanaka Durga Nagar Chengicherla, Hyderabad, Telangana, India – 500092
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Favnox Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Favnox Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Favnox Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Favnox Pharmaceuticals Private Limited, buy the company report.
Financials of Favnox Pharmaceuticals Private Limited
FY 2025 filings availableFavnox Pharmaceuticals Private Limited reported revenue of ₹8.66 Cr (up 258% YoY) for FY 2024.
Revenue · FY 2024
₹8.66 Cr ▲ 258%
Net profit · FY 2024
₹8.9 Lakh margin 1%
EBITDA · FY 2024
₹14.81 Lakh margin 1.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 258%
3 years · compounded
▲ 77%
EBITDA CAGR growth
1 year
▲ 73%
3 years · compounded
▲ 74%
Revenue has grown at a compounded annual rate (CAGR) of 77% over three years, including 258% growth in the latest year. EBITDA rose 73% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹14.81 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹8.9 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 1.7% | |||
| Net Profit Margin | 1% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Favnox Pharmaceuticals Private Limited, buy the company report.
Board of directors of Favnox Pharmaceuticals Private Limited
Favnox Pharmaceuticals has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sushant Kumar Gantayata | Director | 21 Aug 2022 | 4 Years 2 Months | Current |
| Avanti Malve | Director | 29 Aug 2020 | 6 Years 2 Months | Current |
| Shreenath Panigrahy | Director | 29 Aug 2020 | 6 Years 2 Months | Current |
Peer comparison
Favnox Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Axial Pharmaceuticals Private Limited | ₹9.01 Cr (FY 2024) | -15.0% | Vadodara, Gujarat, India | |||
| Metro Pharmaceuticals Private Limited | ₹8.95 Cr (FY 2024) | 16.0% | Delhi, India | |||
| Favnox Pharmaceuticals Private Limitedthis company | ₹8.66 Cr (FY 2024) | ₹8.9 Lakh | 1% | 258.0% | Hyderabad, Telangana, India | |
| MSK Pharmaceuticals Private Limited | ₹8.64 Cr (FY 2025) | 55.0% | Saraipali, Chhattisgarh, India | |||
| Modasa Pharmaceuticals Private Limited | ₹8.58 Cr (FY 2025) | 37.0% | Modasa, Gujarat, India |
To see the full peer comparison of Favnox Pharmaceuticals Private Limited, buy the company report.
Auditor
Favnox Pharmaceuticals Private Limited is audited by A D N AND ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A D N AND ASSOCIATES | FY 2022 | 332503E |
Shareholding
The shareholding of Favnox Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Favnox Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Favnox Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Favnox Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Favnox Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 04, 2024.
Active EPFO establishments
1
GST
Favnox Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAECF2118H1ZX | Telangana | Active | 16 Oct 2020 |
To see the full GST registrations and return filing status of Favnox Pharmaceuticals Private Limited, buy the company report.
Recent activity
Favnox Pharmaceuticals Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Sushant Kumar Gantayata was appointed as Director on 21 Aug 2022.
AGM
Favnox Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Favnox Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Appointed
Sushant Kumar Gantayata was appointed as Director.
Appointed
Avanti Malve was appointed as Director.
Appointed
Shreenath Panigrahy was appointed as Director.
Incorporation
29 Aug 2020
Favnox Pharmaceuticals Private Limited was registered on 29 Aug 2020 with Roc Hyderabad & aged 6 years 2 months as per MCA records.
Frequently asked questions
Favnox Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 August 2020 (6+ years old) and is registered under CIN U24239TG2020PTC143312.
Favnox Pharmaceuticals has 3 current directors:
- Sushant Kumar Gantayata - Director
- Avanti Malve - Director
- Shreenath Panigrahy - Director
The latest financial statements of Favnox Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Favnox Pharmaceuticals is 36AAECF2118H1ZX, registered in Telangana.
The CIN (Corporate Identification Number) of Favnox Pharmaceuticals is U24239TG2020PTC143312. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Favnox Pharmaceuticals was incorporated on 29 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Favnox Pharmaceuticals by revenue are Axial Pharmaceuticals Private Limited, Metro Pharmaceuticals Private Limited, MSK Pharmaceuticals Private Limited, Modasa Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Sushant Kumar Gantayata was appointed as Director on 21 Aug 2022. Avanti Malve was appointed as Director on 29 Aug 2020. Shreenath Panigrahy was appointed as Director on 29 Aug 2020.
Yes, Favnox Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-20-0004478).
Favnox Pharmaceuticals can be reached through the website favnox.in. Its registered office is in Hyderabad, Telangana, India.
The registered office of Favnox Pharmaceuticals is at Plot No 92 Kanaka Durga Nagar Chengicherla, Hyderabad, Telangana, India – 500092.